PCM
CLVS

Pentwater Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Pentwater Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-11,700
Closed -$1.03M – 169
2015
Q2 		$1.03M Buy
+11,700
New +$1M 0.01% 153
2014
Q2 		– Sell
-10,000
Closed -$693K – 170
2014
Q1 		$693K Sell
10,000
-30,000
-75% -$2.2M 0.02% 109
2013
Q4 		$2.41M Hold
40,000
– – 0.07% 90
2013
Q3 		$2.43M Buy
+40,000
New +$2.84M 0.07% 90

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Pentwater Capital Management's CLVS Position: Q1 2015 in Review

Pentwater Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2015, closing a stake of 494,600 shares — an estimated $27.7M sold.

Pentwater Capital Management first reported a position in CLVS in Q4 2013 and held it in 5 quarters. The position peaked at $29.5M in Q3 2014. 152 funds tracked by Wall St. Rank hold CLVS as of Q1 2015.

  • Pentwater Capital Management reported no remaining Clovis Oncology, Inc. position as of Q1 2015 after selling out during the quarter.
  • Pentwater Capital Management sold 494,600 Clovis Oncology, Inc. shares in Q1 2015, an estimated $27.7M.
  • Pentwater Capital Management first reported a position in Clovis Oncology, Inc. in Q4 2013 and held it in 5 quarters.
  • Pentwater Capital Management's Clovis Oncology, Inc. position peaked at $29.5M in Q3 2014.
  • 152 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2015.

Based on Pentwater Capital Management's 13F filing for Q1 2015, filed 15 May 2015.